AnaptysBio Announces Positive Top-Line Proof-of-Concept Data For ANB020 In Moderate-to-Severe Baseline
pharmaceutical investing Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update
CoTec Holdings Corp. Notes HyProMag USA Pre-Feasibility Study Outlining Future Expansion Options to Quadruple Planned U.S. Rare Earth Magnet Capacity, Indicating an Incremental Post-Tax NPV of Up to US$2.1 billion
Star Copper Expands Historical Copper System with Largest Drill Program in Project History with Pervasive Mineralization Across Multiple Intercepts
